Probing the gastrointestinal immune function using transgenic and knockout technology

Current Opinion in Gastroenterology

Volumn 12, Issue 6, 1996, Pages 577-583

  Morales, Victor M ^a   Snapper, Scott B ^b   Blumberg, Richard S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL TRACT; IMMUNE SYSTEM; MOUSE; NONHUMAN; REVIEW; TECHNOLOGY; TRANSGENE;

EID: 0029832866     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199611000-00015     Document Type: Review

References (65)

1. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH: Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci U S A 1980, 77:7380-7384.
2. Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS: Insertion of DNA sequences into human chromosomal β-globin locus by homologous recombination. Nature 1985, 317:230-234.
3. Gossler A, Doetschman T, Korn R, Sertling E, Kemler R: Transgenesis by means of blastocyst-derived embrionic stem cell lines. Proc Natl Acad Sci U S A 1986, 83:9065-9069.
4. Thomas KR, Capecchi MR: Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987, 51:503-512.
5. Galli-Taliadoros LA, Sedgwick JD, Wood SA, Körner H: Gene knock out technology: a methological overview for the interested novice. J Immunol Methods 1995, 181:1-15. A good review of the basic techniques.
6. Majzoub JA, Muglia LJ: Molecular medicine: knockout mice. N Engl J Med 1996, 334:904-907.
7. Brandon EP, Idzerda RL, McKnight GS: Targeting the mouse genome: a compendium of knockouts (part I). Curr Biol 1995, 5:625-634. This is the first part of a list of the knockouts obtained each with a short description of their phenotypes and citations. Parts II and III were published in subsequent issues. More current information can be obtained through the world wide web at http://www.cursci.co.uk/biomednet/biomedbi.html or at http:/www.gdb.org/Dan/tbase/tbase.html.
8. Shastry BS: Genetic knockouts in mice: an update. Experientia 1995, 51:1028-1039.
9. Chien KR: Molecular medicine in genetically engineered animals: series introduction. J Clin Invest 1996, 97:2. This is the introduction to a series of 10 articles, published in this and following issues. They are excellent overviews with technologic details of the knockout technique, its variations, the range of applications, and the future goals for further developments.
10. Kagnoff MF, Kiyono H: Essentials of Mucosal Immunology. San Diego: Academic Press; 1996. Most of the chapters in this book are short but excellent reviews with up-to-date information.
11. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, Alt FW: Rag-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement Cell 1992, 68:855-867.
12. Rocha B, Vassalli P, Guy-Grand D: Thymic and extrathymic origins of gut intraepithelial lymphocyte population in mice. J Exp Med 1994, 180:681-686.
13. Sato K, Ohtsuka K, Hasegawa K, Yamigiwa S, Watanabe H, Asakura H, Abo T: Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 1995, 182:759-767.
14. + cells and liver CD4+NK1+ T cell receptor αβ+ cells in T cell factor-1-deficient mice. Eur J Immunol 1996, 26:351-355. A thorough analysis of the effects of the mutation on lymphoid cell populations.
15. Abo T, Watanabe H, Sato K, Iiai T, Moroda T, Takeda K, Seki S: Extrathymic T cells at an intermediate phylogenetic position between natural killer cells and thymus derived T cells. Nat Immunol 1996, 14:173-187.
16. Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, Obana S, Mombaerts P, Tonegawa S, Yamamoto H, Itohara S, Nanno M, Ishikawa H: Homeostatic regulation of intestinal epithelia by intraepithelial γδ T cells. Proc Natl Acad Sci U S A 1995, 92:6147-6151.
17. Nishimura H, Emoto M, Hiromatsu K, Yamamoto S, Matsuura K, Gomi H, Ikeda T, Itohara S, Yoshikai Y: The role of γδ T cells in priming macrophages to produce tumor necrosis factor-α Eur J Immunol 1995, 25:1465-1468.
18. Ramsay AJ: Genetic approaches to the study of cytokine regulation of mucosal immunity, Immunol Cell Biol 1995, 73:484-488.
19. Kopf M, Le Gros G, Coyle AJ, Kosco-Vilbois M, Brombacher F: Immune response of IL-4, IL-5, IL-6 deficient mice, Immunol Rev 1995, 148:45-69.
20. Brandtzaeg P: Basic mechanisms of mucosal immunity: a major adaptative defense system. Immunologist 1995, 3:89-96.
21. Hendrickson BA, Rindisbacher L, Corthesy B, Kendall D, Waltz DA, Neutra MR, Seidman JG: Lack of association of secretory component with IgA in J chain-deficient mice. J Immunol 1996, 157:750-754. This report clearly proves the importance of the J chain for secretion of polymeric immunoglobulin A and suggests the existence of a secretory complex-independent secretion mechanism.
22. Fearon DT, Locksley RM: The Instructive role of innate immunity in the acquired immune response. Science 1996, 272:50-54.
23. Mosman TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996, 17:138-146.
24. + T cells. Eur J Immunol 1994, 24:343-347.
25. Noben-Trauth N, Kropf P, Müller I: Susceptibility to Leishmania major infection in interleukin-4-deflcient mice. Science 1996, 271:987-990.
26. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G, Scott P: IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental Leishmanlasis. J Immunol 1995, 154:5320-5330.
27. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G: Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996, 26:1553-1559.
28. van den Broek MF, Müller U, Huang S, Zinkernagel RM, Aguet M: Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 1995, 148:5-18.
29. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DAA, Doherty PC, Grosveld GC, Ihle JN: Requirement for Stat4 In interleukin-12-mediated response of natural killer and T cells. Nature 1996, 382:171-174.
30. Kaplan MH, Sun Y-L, Hoey T, Grusby MJ: Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deflcient mice. Nature 1996, 382:174-177.
31. Meeyard L, Hovenkamp E, Otto SA, Miedema F: IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 1996, 156:2776-2782.
32. Flesch IEA, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H, Kaufmann HE: Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J Exp Med 1995, 181:1615-1621.
33. Schijns VECJ, Wierda CMH, van Hoeij M, Horzinek MC: Exacerbated viral hepatitis in IFN-γ repector-deficient mice is not suppressed by IL-12. J Immunol 1996, 157:815-821.
34. Dianda L, Gulbrason-Judge A, Pao W, Hayday AC, MacLennan ICM, Owen MJ: Germinal center formation in mice lacking αβ T cells. Eur J Immunol 1996, 26:1603-1607.
35. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994, 264:703-707.
36. Neumann B, Luz A, Pfeffer K, Holzmann B: Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med 1996, 184:259-264.
37. Okahashi N, Yamamoto M, Vancott JL, Chatfield SN, Roberts M, Bluethmann H, Hirol T, Kiyono H, McGhee JR: Oral immunization of Interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immnunoglobulin A responses. Infect Immunity 1996, 64:1516-1525. This report shows that mucosal IgA responses can occur independently of interleukin-4.
38. Kopf M, Ramsay A, Brombacher F, Baumann H, Freer G, Galanos C, Gutierrez-Ramos J, Kohler G: Pleiotropic effects of IL-6-deficient mice including early hematopoiesis, T and B cell functions, and acute phase responses. Ann N Y Acad Sci 1995, 762:308-318.
39. Beagley KW, Bao S, Ramsay AJ, Eldridge JH, Husband AJ: IgA production by peritoneal cavity B cells is IL-6 independent: implications for intestinal IgA responses. Eur J Immunol 1995, 25:2123-2126.
40. Bromander AK, Ekman L, Kopf M, Nedrud JG, Lycke NY: IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J Immunol 1996, 156:4290-4297. This report adds interleukin-6 to the list of factors that have been shown not to be required for cholera toxin adjuvant activity. Cholera toxin strongly induces the production of IL-6 by antigen-presenting cells and it is likely that although this cytokine is involved in the adjuvant mechanism of cholera toxin, its function may overlap with other cytokines such as interleukin-5 or -10.
41. Kopf M, Brombacher F, Hodgkin PD, Ramsay A, Milbourne EA, Dai WJ, Ovington KS, Behm CA, Köhler G, Young IG, Matthaei KI: IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15-24.
42. Powrie F: T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995, 3:171-174.
43. Sartor RB: Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis. Inflamm Bowel Dis 1995, 1:64-75.
44. Elson CO, Sartor RB, Tennyson G, Riddel R: Experimental models of inflammatory bowel disease. Gastroenterology 1995, 109:1344-1367.
45. Saddlack B, Merz H, Schorle H, Schimpi A, Feller A, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261.
46. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995, 3:521-530.
47. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
48. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh C-G, Gress RE, Karlsson S: Transforming growth factor-β null mice: an animal model for inflammatory disorders. Am J Pathol 1995, 146:264-275.
49. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994, 76:969-976.
50. Reinecker H-C, Podolsky DK: Human intestinal epithelial cells express functional cytokine receptors sharing the common γc chain of the interleukin 2 receptor. Proc Natl Acad Sci U S A 1995, 92:8353-8357.
51. Thompson FM, Mayrhofer G, Cummins AG: Dependence of epithelial growth of the small intestine on T-cell activation during weaning in the rat Gastroenterology 1996, 111:37-44.
52. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S: Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993, 75:275-282.
53. 2m: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112.
54. Holländer GA, Simpson SJ, Mizoguchi E, Nichogiannopoulus A, She J, Gutierrez-Ramos J-C, Bhan AK, Burakoff SJ, Wang B, Terhorst C: Severe colitis in mice with aberrant thymic selection. Immunity 1995, 3:27-38.
55. + T cells. J Exp Med 1993, 178:237-244.
56. Bucy RP, Xu XY, Li J, Huang GQ: Cyclosporin A-induced autoinmmune disease in mice. J Immunol 1993, 151:1039-1050.
57. 12-deficient mice. Nat Genet 1995, 10:143-150.
58. Hermiston ML, Gordon JI: Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995, 270:1203-1207.
59. Hermiston ML, Gordon JI: In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol 1995, 129:489-506. This article reports an elegant use of chimeric mice to study the function of cadherins in the intestinal epithelial cells' growth progression. In this particular case, a dominant negative mutant N-cadherin gene has been placed under the control of a promoter for expression in the intestinal epithelium. Some of the crypt epithelial cells in the intestine express the mutant gene and display the effects associated with the lack of function. Approaches like this one could be useful to circumvent the developmental problems encountered when the gene under study is critical for survival of the embryo.
60. + T cells are responsible for the murine interleukin-2-deficient colitis. Eur J Immunol 1995, 25:2618-2625.
61. Ma A, Datta M, Margosian E, Chen J, Horak I: T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J Exp Med 1995, 182:1567-1572.
62. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez Sueiro JL, Balish E, Hammer RE: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994, 180:2359-2364.
63. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int Immunol 1993, 5:1461-1471.
64. Rajewsky K, Gu H, Kühn R, Betz UAK, Müller W, Roes J, Schwenk F: Conditional gene targeting. J Clin Invest 1996, 98:600-603.
65. Marth JD: Recent advances in gene mutagenesis by site-directed recombination. J Clin Invest 1996, 97:1999-2002.